title: Electrochemotherapy in advanced skin tumors and cutaneous metastases - a retrospective multicenter analysis.
abstract: OBJECTIVE
  Once classic treatments such as chemotherapy or radiation therapy have been exhausted, only few therapeutic options remain for extensive skin tumors or cutaneous metastases. In such cases, electrochemotherapy may be considered as alternative therapy.
  
  
  METHODS
  In this retrospective study, clinical features, treatment response, and adverse effects were evaluated in 56 patients treated with electrochemotherapy at six German dermatology departments.
  
  
  RESULTS
  The mean age of the patient cohort (14 men, 42 women) was 69.3 years. Included were 20 patients with skin metastasis of advanced malignant melanoma, 13 patients with breast cancer metastases, 15 patients with primary squamous cell carcinoma of the skin or cutaneous metastases of other carcinoma types, and 8 patients with cutaneous lymphoma or sarcoma. The overall response rate was 44.6% (10.7% complete response; 33.9% partial response). By contrast, 31 (55.4%) patients did not respond (12.5% had stable disease; 42.9%, tumor progression). Patients with melanoma and cutaneous lymphoma or sarcoma responded significantly better than those with carcinoma. Roughly one quarter of patients showed an improvement in tumor-related exudation, fetor, and chronic bleeding.
  
  
  CONCLUSIONS
  Showing only few adverse effects, electrochemotherapy was effective in about one half of the patients with advanced tumors. Treatment response appears to depend on the tumor entity.
authors.affiliation: Department of Dermatology, Venereology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Kreuter
authors.forename: Tina
authors.initials: T
authors.lastname: van Eijk
authors.forename: Percy
authors.initials: P
authors.lastname: Lehmann
authors.forename: Matthias
authors.initials: M
authors.lastname: Fischer
authors.forename: Thomas
authors.initials: T
authors.lastname: Horn
authors.forename: Chalid
authors.initials: C
authors.lastname: Assaf
authors.forename: Gaston
authors.initials: G
authors.lastname: Schley
authors.forename: Rudolf
authors.initials: R
authors.lastname: Herbst
authors.forename: Ivonne
authors.initials: I
authors.lastname: Kellner
authors.forename: Christiane
authors.initials: C
authors.lastname: Weisbrich
authors.forename: Julia
authors.initials: J
authors.lastname: Hyun
authors.forename: Ulrike
authors.initials: U
authors.lastname: Wieland
authors.forename: Max
authors.initials: M
authors.lastname: Schlaak
authors.forename: Albert
authors.initials: A
authors.lastname: Rübben
authors.forename: Kerstin
authors.initials: K
authors.lastname: Lommel
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D053672:Electrochemotherapy / Q000379:methods*; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents